CHADDS FORD, Pa. — Endo's parent company is looking to change its name and will integrate four of its operating units, the drug maker said Thursday.
Endo said the company, currently called Endo Pharmaceutical Holdings, would ask shareholders to approve changing the name to Endo Health Solutions at its annual shareholder meeting in May.
Endo also aggregated AMS, its medical device unit; Endo Pharmaceuticals, its branded drug unit; HealthTronics, its medical services unit; and Qualitest, its generic drugs unit. The company said the four would share "visual and verbal identity standards" with that of the parent company.
"With the right organizations in place, we have modernized our four distinct operating companies into an enterprise that reflects a powerful combination of compatible organizations aimed at delivering fully integrated healthcare solutions for the benefit of physicians, payers and patients," Endo president and CEO Dave Holveck said. "We are excited to be setting a new standard for healthcare solutions delivery."